Answers are grounded in this paper and cite their sources.
Congenital intracranial-extracranial communicating mixed germ cell tumors (MGCTs) are extremely rare in infants, with no standardized treatment protocol. We report a 2-month-old female infant with giant congenital intracranial-extracranial communicating MGCT accompanied by typical "crater-like" skull defect. Preoperative serum alpha-fetoprotein (AFP) was significantly elevated, while β-human chorionic gonadotropin (β-HCG) was within normal range. Maximal safe resection was performed, and pathology confirmed mixed germ cell tumor (immature teratoma WHO grade 3 + yolk sac tumor). Next-generation sequencing identified a novel ARID1B c.1628C>G (p.A543G) somatic mutation, previously unreported in pediatric intracranial MGCTs. Postoperative imaging confirmed subtotal resection with continuous AFP decline. No tumor recurrence was observed during 3-month follow-up. This case expands the genomic mutation spectrum of pediatric intracranial MGCTs and supports maximal safe resection as first-line treatment for this rare infantile tumor.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: